Skip to main content
Fig. 1 | Journal for ImmunoTherapy of Cancer

Fig. 1

From: Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

Fig. 1

Kaplan-Maier PFS curves of melanoma patient treated with nivolumab. a Patients stratified according baseline neutrophils-to lymphocyte ratio (NLR). Green line: NLR ≥ 5; Blue line: NLR < 5. b Patients stratified according baseline derived neutrophils-to lymphocyte ratio (dNLR). Green line: dNLR≥3; Blue line: dNLR< 3

Back to article page